TY - JOUR
T1 - Plasma Levels of Brain-Derived Neurotrophic Factor are Associated with Prognosis in the Acute Phase of Ischemic Stroke
AU - Mourão, Aline Mansueto
AU - Vicente, Laélia Cristina Caseiro
AU - Abreu, Mery Natali Silva
AU - Vale Sant'Anna, Romeu
AU - Vieira, Erica Leandro Marciano
AU - de Souza, Leonardo Cruz
AU - de Miranda, Aline Silva
AU - Rachid, Milene Alvarenga
AU - Teixeira, Antônio Lucio
N1 - Publisher Copyright:
© 2018 National Stroke Association
PY - 2019/3
Y1 - 2019/3
N2 - Context: Brain-derived neurotrophic factor (BDNF) is a neurotrophin involved in neuronal survival, differentiation, and maturation. Purpose: To evaluate the levels of BDNF in the acute phase of stroke and their potential association with neurological impairment. Methods: Patients in the acute phase of ischemic stroke were evaluated with the following clinical tools: National Institutes of Health Stroke Scale, modified Rankin scale, Gugging Swallowing Screen and Alberta Stroke Program Early CT Score. Blood samples were collected at 3 different moments of hospital stay. BDNF was measured through enzyme-linked immunosorbent assay. Results: Patients who were discharged after 10 days had worse clinical outcomes and higher levels of BDNF since admission. There was correlation between BDNF levels and clinical parameters. Conclusion: BDNF levels were associated with clinical prognosis in the acute phase of ischemic stroke.
AB - Context: Brain-derived neurotrophic factor (BDNF) is a neurotrophin involved in neuronal survival, differentiation, and maturation. Purpose: To evaluate the levels of BDNF in the acute phase of stroke and their potential association with neurological impairment. Methods: Patients in the acute phase of ischemic stroke were evaluated with the following clinical tools: National Institutes of Health Stroke Scale, modified Rankin scale, Gugging Swallowing Screen and Alberta Stroke Program Early CT Score. Blood samples were collected at 3 different moments of hospital stay. BDNF was measured through enzyme-linked immunosorbent assay. Results: Patients who were discharged after 10 days had worse clinical outcomes and higher levels of BDNF since admission. There was correlation between BDNF levels and clinical parameters. Conclusion: BDNF levels were associated with clinical prognosis in the acute phase of ischemic stroke.
KW - biomarker
KW - Brain-derived neurotrophic factor
KW - ichemic stroke
KW - prognosis
KW - stroke
KW - stroke outcome
UR - http://www.scopus.com/inward/record.url?scp=85057558923&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057558923&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2018.11.013
DO - 10.1016/j.jstrokecerebrovasdis.2018.11.013
M3 - Article
C2 - 30522804
AN - SCOPUS:85057558923
SN - 1052-3057
VL - 28
SP - 735
EP - 740
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
IS - 3
ER -